Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
P. R. health sci. j ; 25(2): 137-142, Jun. 2006.
Article in English | LILACS | ID: lil-472189

ABSTRACT

The objective of this study is to determine the influence of several personal and lifestyle factors on the levels of circulating vitamin C in a population of children. To accomplish this objective, blood samples were collected from 511 healthy children residing in the Greater San Juan area. The population was stratified into 4 percentile groups (approaching quartiles) according to plasma ascorbate levels from lowest to highest concentrations. Comparisons were made between percentile groups on the basis of age, gender, body mass index (BMI), dietary intake of vitamin C (corrected and uncorrected for energy intake) and exposure to environmental tobacco smoke (ETS). Smoke exposure was determined using urinary cotinine, which is a highly sensitive bioindicator for ETS. Dietary vitamin C was determined via one 24hr recall questionnaire. When all 4 percentile groups were used as a basis of comparison, no differences were noted for any of the factors between groups, however when comparing percentile group 1 (lowest blood ascorbate) to an aggregate value of percentile, groups 2-4, it was found that vitamin C intake (corrected for energy intake) paralleled blood values with a statistically significant association. Among personal and environmental factors only exposure to ETS showed a significant difference in blood levels between groups 2-4 and group 1. No differences between percentile groups were noted for age gender or BMI. These results emphasize that ETS is strongly associated with lowered blood ascorbate levels with the obvious implication of reduced antioxidant protection and increased risk of adverse health consequences.


Subject(s)
Humans , Male , Female , Adolescent , Ascorbic Acid/administration & dosage , Ascorbic Acid/blood , Tobacco Smoke Pollution/adverse effects , Age Factors , Body Mass Index , Calorimetry , Child , Child, Preschool , Cotinine/urine , Creatinine/urine , Data Interpretation, Statistical , Diet , Energy Intake , Enzyme-Linked Immunosorbent Assay , Life Style , Surveys and Questionnaires , Sex Factors , Time Factors
2.
P. R. health sci. j ; 23(3): 183-188, Sept. 2004.
Article in English | LILACS | ID: lil-406545

ABSTRACT

Liver transplantation is the only treatment for end-stage liver disease. It is costly, difficult, and not performed in Puerto Rico. For these reasons, it has been a limited option for Puerto Ricans with advanced cirrhosis, especially for those with no medical insurance to cover for the procedure. In an effort to improve access to the procedure and offer this chance of life to more Puerto Ricans facing death from complications of advanced liver disease, the Gastroenterology and Liver Diseases Division of the University of Puerto Rico, in collaboration with LifeLink Transplant Institute in Tampa, Florida and the Office of Catastrophic Funds of the Commonwealth of Puerto Rico, opened a clinic for liver transplant evaluation at the Medical Sciences Campus. The purpose of this clinic is to coordinate the pre-transplant evaluation of candidates for this therapy, provide the evaluation by the transplant surgeon in Puerto Rico, expedite the process in seriously ill patients, and offer post-transplant follow-up upon the patient's return to Puerto Rico. The purpose of this article is to describe the experience in this clinic from 1999 to 2003. One hundred ninety-three patients were seen from September 1999 to January 2003. The most common causes for liver disease were hepatitis C and alcohol, alone or in combination. One hundred thirty four were accepted as candidates for evaluation. Of these, 63 had completed the process, 33 were listed for transplantation and 21 had been transplanted by January 2003. Neither education level, marital status, health insurance nor Child score were associated with successful outcome. This clinic offers Puerto Ricans, especially those with limited resources, with a viable access to liver transplantation.


Subject(s)
Humans , Male , Female , Middle Aged , Liver Transplantation/statistics & numerical data , Chronic Disease , Academic Medical Centers/statistics & numerical data , Postoperative Care/methods , Preoperative Care/methods , Health Services Accessibility , Puerto Rico/epidemiology , Socioeconomic Factors , Liver Transplantation/methods
3.
P. R. health sci. j ; 23(1): 9-12, Mar. 2004.
Article in English | LILACS | ID: lil-359655

ABSTRACT

This study analyzes health, growth and neurodevelopmental outcome of infants who received prenatal corticosteroids with or without thyroxine for fetal lung maturation. During a 12 month period infants from a prospective double blind study who received either steroids or steroids combined with thyroxine for pulmonary maturation and who had reached 18 months of age were recalled for evaluation of health status, growth parameters and neurodevelopmental outcome using the Bayley Scales 2nd edition (BSID-II). Mental developmental index (MDI), psychomotor developmental index (PDI), language developmental age (LDA), cognitive developmental age (CDA), and behavioral rating scales (BRS) were compared for the two treatment groups. The Hollingshead Socioeconomic Status Index was determined for each infant. Of a total of 134 patients enrolled during the study period, 66 patients return for follow up. Data from 60 patients was included in the final analysis. Of these, 32 had received the combination regimen and 28 had solely received only steroids. Demographics and neonatal morbidity were similar in both groups. No statistical differences in growth parameters, hospital admissions, respiratory problems, surgical procedures or frequency of infections were found. Neurodevelopmental parameters (MDI, PDI) were similar in both treatment groups, although, below normal in both groups. Language delay was more common in infants who received prenatal corticosteroids. There were no difference in the incidence of neurologic abnormalities. The addition of thyroxine to steroids did not affect growth or neuro-developmental outcome of the infants at 18 to 22 postnatal age.


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Adrenal Cortex Hormones/therapeutic use , Respiratory Distress Syndrome, Newborn/prevention & control , Thyroxine/therapeutic use , Age Factors , Apgar Score , Birth Weight , Child Development , Adrenal Cortex Hormones/administration & dosage , Adrenal Cortex Hormones/adverse effects , Data Interpretation, Statistical , Double-Blind Method , Drug Therapy, Combination , Follow-Up Studies , Health Status , Neurologic Examination , Neuropsychological Tests , Parents , Physical Examination , Prospective Studies , Lung/embryology , Socioeconomic Factors , Time Factors , Treatment Outcome , Thyroxine/administration & dosage , Thyroxine/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL